Waage v. Cutter Biological Division of Miles Laboratories, Inc.

926 P.2d 1145, 1996 Alas. LEXIS 140
CourtAlaska Supreme Court
DecidedNovember 22, 1996
DocketS-6059/6849
StatusPublished
Cited by12 cases

This text of 926 P.2d 1145 (Waage v. Cutter Biological Division of Miles Laboratories, Inc.) is published on Counsel Stack Legal Research, covering Alaska Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Waage v. Cutter Biological Division of Miles Laboratories, Inc., 926 P.2d 1145, 1996 Alas. LEXIS 140 (Ala. 1996).

Opinion

OPINION

RABINOWITZ, Justice.

I. INTRODUCTION

Christopher Waage is a hemophiliac who infused “Koate,” a blood-clotting agent manufactured by the Cutter Biological Division of Miles Laboratories, Inc. (Miles). Waage sued Miles in September 1990, alleging that he contracted the AIDS virus from a batch of contaminated Koate he used in 1983. The superior court granted summary judgment in favor of Miles, ruling that the applicable statute of limitations had expired on Waage’s claim. We reverse.

II. FACTS AND PROCEEDINGS

A. Waage’s Lawsuit

In 1983 Kodiak resident Christopher Waage was treating his hemophilia with Koate, a blood coagulant that Miles manufactured from human blood plasma. In October 1983, Miles recalled several lots of Koate containing plasma from a donor who had *1147 been diagnosed with AIDS. Miles’ letter to Waage’s direct Koate supplier, the Oregon Health Sciences University (OHSU), stated that “there is no evidence these products will transmit [AIDS].” OHSU immediately informed Waage of the recall by a letter which also stated that “[t]here is no indication that anyone who has infused the [Koate] has become ill. We do not recommend any special laboratory tests other than the blood samples which are collected when you come to clinic.” 1

By the time he received OHSU’s letter, however, Waage had already used some of the AIDS tainted Koate. As early as 1986 or 1987, Waage began to discuss with family members the subject of his possible HIV positive status and whether he should undergo testing. Waage later stated, “Until the test results came back I was worried about the exposure, ... but believed due to my generally healthy physical condition that I was not infected. The longer time passed the more I was convinced I was not infected.” Waage would tell, people “that I may have been exposed [to the AIDS virus], and then I would just say, ‘but I don’t have it.’ There’s a chance in hell that I have it, you know?”

In October 1987 Waage received a letter from Dr. Lovrien of OHSU that stated, in part:

Regarding the risk of AIDS. I think that what is important is whether you feel well or not. It is most likely that you are probably going to test as AIDS HIV antibody positive since most [of] the fellows with hemophilia your age are positive. However, most of them are not sick and I think this is important to remember that the HIV test is just a laboratory test and does not tell us whether or not you are sick or not.... We will be coming back up there and we can certainly help arrange for you to be tested if you like. Another way is to somehow arrange for you to come down here. At any rate I think it is important to stay in touch and let us try to help you in any way we can.

When Dr. Lovrien came to Kodiak to treat several hemophiliacs, Waage declined testing.

In August 1988, after injuring his knee in a fall, Waage saw Dr. Juergens in Kodiak. He was also suffering from considerable weight loss and night sweats. Juergens informed Waage that she suspected he was HIV positive, and she suggested that he undergo HIV testing.

Waage subsequently travelled to Seattle and on August 10 was examined by Dr. Bush. Dr. Bush noted that Waage’s weight loss and feverish symptoms had abated, and concluded that “it is not imperative to proceed with testing at this time although [Waage] may benefit from AZT.” Waage nevertheless did undergo testing on September 2, 1988, and tested positive for the HIV virus on September 3 and on September 9, according to two separate tests which were administered. Waage claims that he received the test results in either October or November of 1988.

Waage filed suit against Miles on September 10, 1990, alleging negligence, products liability, and breach of implied warranty. 2

B. Miles Obtains Summary Judgment an Statute of Limitations Grounds

Prior to trial, Miles moved for summary judgment, arguing that the two-year statute of limitations on Waage’s claims had expired before September 7,1990. Miles argued that undisputed facts showed that before September 1988, Waage knew that he was possibly or even probably HIV positive, and that “discovery of his HIV status could have been quickly and easily accomplished.” Miles asserted that more than two years before Waage filed suit, he was in possession of information sufficient to cause a reasonable person to make inquiries to protect his rights, and that had Waage inquired, he would have discovered the elements of his cause of action. In response, Waage argued in part that the statute of limitations should be tolled on the grounds that Miles had *1148 concealed information about Koate’s dangerousness.

The superior court granted Miles’ summary judgment motion and subsequently denied Waage’s Motion for Reconsideration. It concluded that “undisputed facts ... show that Mr. Waage knew or should have known of his cause of action more than two years prior to ... the date on which the Plaintiff commenced suit.” Waage appeals from this judgment. 3

III. DISCUSSION 4

The superior court granted summary judgment in favor of Miles based upon its determination that the applicable statute of limitations had run, barring Waage’s claim. The applicable statute of limitations for tort claims is two years. AS 09.10.070. In resolving the issues presented in this appeal, it is necessary to examine the related doctrines of equitable estoppel and the discovery rule. 5

In Cameron v. State, 822 P.2d 1362, 1366 (Alaska 1991), discussing the discovery rule as summarized in our earlier opinion in Mine Safety Appliances Co. v. Stiles, 756 P.2d 288 (Alaska 1988), we said:

This is a formulation of the discovery rule that will work for most, but not all cases. Most notably it mentions two ae-crual dates: (1) the date when plaintiff reasonably should have discovered the existence of all essential elements of the cause of action; and (2) the date when the plaintiff has information which is sufficient to alert a reasonable person to begin an inquiry to protect his rights. The dates are different, since the point when the elements of a cause of action are discovered may come after and as a result of a reasonable inquiry. The inquiry, in turn, may be a time consuming process.
In Mine Safety and in other eases, we held that the inquiry notice date, rather than the date when the inquiry should have produced knowledge of the elements of the cause of action, was the date from which the statutory period began to run.[ 6 ]

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Janice L. Park v. Jessica J. Spayd
509 P.3d 1014 (Alaska Supreme Court, 2022)
Harrell v. Calvin
403 P.3d 1182 (Alaska Supreme Court, 2017)
Alaska Fur Gallery, Inc. v. First National Bank Alaska
345 P.3d 76 (Alaska Supreme Court, 2015)
Gefre v. Davis Wright Tremaine, LLP
306 P.3d 1264 (Alaska Supreme Court, 2013)
Jarvill v. Porky's Equipment, Inc.
189 P.3d 335 (Alaska Supreme Court, 2008)
Williams v. Williams
129 P.3d 428 (Alaska Supreme Court, 2006)
Fuller v. City of Homer
113 P.3d 659 (Alaska Supreme Court, 2005)
John's Heating Service v. Lamb
46 P.3d 1024 (Alaska Supreme Court, 2002)
City of Fairbanks v. Amoco Chemical Co.
952 P.2d 1173 (Alaska Supreme Court, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
926 P.2d 1145, 1996 Alas. LEXIS 140, Counsel Stack Legal Research, https://law.counselstack.com/opinion/waage-v-cutter-biological-division-of-miles-laboratories-inc-alaska-1996.